The current invention pertaining to Granted Patent (EP 3134097) helps in Relieving Pain, Stress and Insomnia vide composition that doesn’t require to be consumed within the body and has no harmful effects. This EP Patent is also in advanced prosecution in the US/India, and is granted in Canada and South Africa. The product is already under commercialization in limited capacity by the Patentee.

PATENT NUMBER: EP 3134097

For More details about the technology: Click Here

The Present invention provide technique for improvements as solution to hypoxia generated in conventional plant tissue culture practices. It Provides a chemical compositions when used in effective concentration will improve plants yield, hypoxic tolerance of plants micro propagated through plant tissue culture practice. And, Chemical composition comprises high concentration of potassium nitrate, choline chloride, glutamine acid, L- Glycine, L-Cysteine, Adenine sulphate, D Ca- Pantothenate acid, Sodium silicate and succinic acid derivatives along with plant tissue culture medium and plant growth hormones. Said chemical compositions may be added during multiplication stage, shooting stage and rooting stage along with plant tissue culture medium.

For More details about the technology: Click Here

The current invention has a unique feature that allows effective use of urinal waste to produce electric energy by Mass Flow Controller (MCF). In earlier days, some researchers attempted to integrate MFCs with Urinal systems. However, there is a gap in field trial studies describing pilot-scale MFC systems deployed under real conditions. The present invention has overcome those challenges to make the MFC based Urinal System scalable at large scale.

Patent Application Number: 201911005010

For More details about the technology: Click Here

The materials can be fabricated to hold particles with sizes ranging from 5 to 30nm. This can have applications in health, hygiene, fragrance, perfumery, food, agricultural sector.

For More details about the technology: Click Here

Escape Therapeutics has successfully worked on a number of novel and potentially disruptive technologies including peptides/ proteins and some of them are already in the market, either by themselves, or in collaboration, and has also out-licensed portfolios in the past. Their various technologies/ products can be applied for treating conditions such as Type I diabetes, Myocardial infarction and Chronic heart failure, Osteoarthritis, Scleroderma, thermal burn and radiation injury, Hyperpigmentation, Melanoma, Aging, Wound and scar etc. Escape Therapeutics is currently looking for licensing/sale of their Patent Portfolio (including stake in the entity as well) and/or for allied collaborations.

For more details about the technology: Click Here

This breakthrough technology produces functionalized and dispersed multi-walled carbon nanotubes with better mechanical properties resulting in reduced paint coating costs and ownership costs.

For more details about the technology: Click Here